Business Wire

Ricoh Europe: Collision or Collaboration as Gen Z Joins Workforce?

7.9.2015 08:00 | Business Wire

Del

More than half of workers (52 per cent) say their employers are failing to meet the needs of different generations in the workplace, according to new research commissioned by Ricoh Europe. The stark finding points to a corporate collision course, as for the first time in history a fourth generation – Generation Z – enters the working population.

But what exactly does Generation Z (those currently aged 19 years and younger) want and expect? Do they deserve the crude label given by some as overly demanding screen-swipers in search of instant gratification? A survey of over 3,300 people from all four generations – spanning 22 countries across Europe, the Middle East and Africa – answers this with an emphatic ‘no’.

Generation Zers are unique. They have been strongly shaped by their individualistic Generation X parents, heard stories from their Baby Boomer grandparents and witnessed the errors and successes of Millennials. Combining this with their appetite for all things digital means they have a solid grounding to achieve and educate others in an ever-evolving and demanding business world.

The good news is that the majority of workers (88 per cent) surveyed from all generations believe that having a workforce of different ages is an asset to a company. However, the survey unearthed a key challenge that managers must overcome. Over a third (35 per cent) of older employees expect workplace tensions to increase with the arrival of Generation Z into their companies. With the next wave of technology-led change sure to soon hit and disrupt the workplace further, the need to establish environments that enable and encourage truly harmonious and productive working across the generations is paramount.

David Mills, CEO of Ricoh Europe, said: “Just like the possibilities afforded by digitalisation, the arrival of Gen Zers opens a catalogue of opportunities to all businesses. With only seven per cent of SMBs currently selling across EU borders1, Gen Zers who move on to managerial roles will be perfectly placed to drive borderless working and ensure their business competes in a single regional market. Enterprise organisations stand to benefit, too. The experience and business know-how Gen Zers acquire into the future, coupled with their upbringing of ultra connectivity and collaboration, will see them play the role of agility enablers for bigger businesses. Meanwhile, Gen Z’s constant demand for workstyle innovation – where an ever-present stream of innovative new technologies, products and processes are the norm – will be a key enabler of vertical market players seeking globalisation.”

The survey found that 65 per cent of respondents agree there are fundamental differences in how employees from each generation work. The clearest contrasts emerged in their respective attitudes, expectations and styles of working. Face-to-face communication at work, while still the most preferred method across every group, is in generational decline. Preference for it drops from 77 per cent among Baby Boomers to 58 per cent among Generation Z. Meanwhile, 73 per cent of Generation Z respondents believe their future employer will cater to their needs, opposed to only 48 per cent of the other three generations.

Mills added: “There is no doubt that Gen Z is heading towards a reality crunch and businesses must adapt now. Trying to squeeze employees – particularly Gen Z – into the same traditional ways of working, and forcing them to use the same tools, simply will not work. People are often the biggest differentiator for an organisation and the most successful companies will be those who can empower and engage all generations in their workforce – from the most experienced through to the youngest rising star.”

Find out more at www.ricoh-europe.com/thoughtleadership .

-ends-

| About Ricoh |

Ricoh is a global technology company specializing in office imaging equipment, production print solutions, document management systems and IT services. Headquartered in Tokyo, Ricoh Group operates in about 200 countries and regions. In the financial year ending March 2015, Ricoh Group had worldwide sales of 2,231 billion yen (approx. 18.5 billion USD).

The majority of the company's revenue comes from products, solutions and services that improve the interaction between people and information. Ricoh also produces award-winning digital cameras and specialized industrial products. It is known for the quality of its technology, the exceptional standard of its customer service and sustainability initiatives.

Under its corporate tagline, imagine. change. Ricoh helps companies transform the way they work and harness the collective imagination of their employees.

For further information, please visit www.ricoh-europe.com

1 http://im.ft-static.com/content/images/fc5b30b4-ef4c-11e4-87dc-00144feab7de.pdf

Contact information

Ricoh Europe PLC
Jack Gibson
Tel: +44 (0) 203 033 3766
E-mail: press@ricoh-europe.com
Homepage: www.ricoh-europe.com
Join us on Facebook: www.facebook.com/ricoheurope
Follow us on Twitter: www.twitter.com/ricoheurope
Visit the Ricoh media centre at: www.ricoh-europe.com/press

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom